Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

ReNetX adds Dr. Kevin Malobisky to SAB

ReNetX Bio has added Dr. Kevin Malobisky to its Scientific Advisory Board. Dr. Malobisky, currently the Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics, brings over...

| By Kelley Gipson

Shoreline Biome receives patent for lysis method

Shoreline Biome was recently awarded a patent for the “Combined Lysis Protocol for Comprehensive Cell Lysis.” The patent outlines the method and materials for the lysis of...

| By Kelley Gipson

The Yale Engage Cancer Series kicks off on 10/21

Yale Engage, in conjunction with the Yale Cancer Center, presents the Yale Engage Cancer Series, an interactive webinar series, promoting impactful collaboration between academic experts...

| By Kelley Gipson

2020 Entrepreneur of the Year nominations open

BioCT invites your nominations for the 2020 Entrepreneur of the Year Award. The Entrepreneur of the Year Award was established by BioCT and Shipman and...

| By Kelley Gipson

Newly funded, Stamford’s Sema4 seeks talent

Executives at health care information firm Sema4 believe their business is “well positioned” after recently raising $121 million in new funding and achieving an overall valuation of...

| By Kelley Gipson

Alexion advances on ULTOMIRIS®, amyloidosis

Alexion reports that the Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorization in the European Union for a...

| By Kelley Gipson

FDA grants fast track to BI’s Jardiance

Boehringer Ingelheim has received fast track designation from the FDA for the development of Jardiance (empagliflozin) to prevent hospitalization for heart failure and reduce the risk...